All In Biotech

Free tool

FAERS Monitor: Quillivant Xr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202100 or its brand name (Quillivant Xr, Methylphenidate Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

9,150

Serious

4,614

50% of reports

Hospitalization

1,777

Death reported

445

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,555
  • off label use536
  • headache467
  • anxiety419
  • fatigue390
  • nausea388
  • decreased appetite380
  • insomnia336
  • toxicity to various agents334
  • disturbance in attention320
  • somnolence315
  • product substitution issue298
  • abnormal behaviour291
  • agitation290
  • drug abuse287

Reports by year received

View as table
YearReports
20042
20051
20061
20073
20088
200918
201014
201118
201269
2013291
2014380
2015809
2016672
2017729
2018847
2019570
2020400
2021459
2022664
2023850
2024788
2025807
2026750

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,009 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
abnormal behaviourSignal29117.015.24,343
disturbance in attentionSignal32013.712.33,746
product substitution issueSignal29812.010.72,973
agitationSignal2909.18.12,085
drug abuseSignal2877.97.11,737
toxicity to various agentsSignal3344.64.1930
decreased appetiteSignal3803.83.4776
somnolenceSignal3153.63.2594
anxietySignal4193.43.1711
insomniaSignal3362.92.6422
drug ineffectiveSignal1,5552.72.61,792
headache4671.71.6142
off label use5361.41.365
fatigue3901.21.08
nausea3881.11.06

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.